Praised for its ‘dedicated’ team members, Trilegal pairs its multijurisdictional experience with its extensive corporate expertise to handle an array of complex transactions, including inbound and outbound M&A, joint ventures and corporate advisory issues. Yogesh Singh spearheads the group, which demonstrates strengths in e-commerce, e-pharma and media sectors, with his strong track record representing clients in M&A, private equity and marque transactions. Sridhar Gorthi’s arsenal of skills are comprised of corporate law issues and private equity mandates on a domestic and cross-border scale, while Nishant Parikh bolsters the practice with his considerable expertise in mezzanine investments, contentious issues and M&A. Harsh Maggon is notably experienced on both the public and private sides of the corporate arena.
Testimonials
Collated independently by Legal 500 research team.
‘Great team.'
'Their approach is not just legal; they are also sensitive to commercial requirements and follow a solution-based approach.’
Key clients
- Manipal Health Enterprises Private Limited
- AGP HoldCo Limited (Taghleef Industries)
Work highlights
- Advised the Manipal Group (MGHS and MHEPL) in: (a) sale of 41% stake in MHEPL by MGHS and Cypress Holdings to Temasek (Temasek Transaction); (b) acquisition by MGHS of 21.52% stake held by TPG VI in MHEPL (TPG Acquisition); (c) acquisition by MGHS of 8.45% stake held by National Investment and Infrastructure Fund - II (NIIF) in MHEPL (NIIF Transaction); (d) sale of 11% stake in MHEPL by MGHS to TPG VIII (TPG Sale).
- Represented Glenmark Life Sciences Limited ("GLS"), a listed pharmaceutical manufacturer of APIs, in the proposed sale of 75% equity shares of GLS by Glenmark Pharmaceuticals Limited to Nirma Limited. The proposed share sale is for an aggregated consideration of INR 56.51bn, subject to customary closing adjustments.